BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baratelli M, Molist-Badiola J, Puigredon-Fontanet A, Pascual M, Boix O, Mora-Igual FX, Woodward M, Lavazza A, Capucci L. Characterization of the Maternally Derived Antibody Immunity against Rhdv-2 after Administration in Breeding Does of an Inactivated Vaccine. Vaccines (Basel) 2020;8:E484. [PMID: 32872139 DOI: 10.3390/vaccines8030484] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Hall RN, King T, O'Connor TW, Read AJ, Vrankovic S, Piper M, Strive T. Passive Immunisation against RHDV2 Induces Protection against Disease but Not Infection. Vaccines (Basel) 2021;9:1197. [PMID: 34696305 DOI: 10.3390/vaccines9101197] [Reference Citation Analysis]
2 Shin S, Park SH, Park J, Kim S, Lee MJ. Age-Dependent Dynamics of Maternally Derived Antibodies (MDAs) and Understanding MDA-Mediated Immune Tolerance in Foot-and-Mouth Disease-Vaccinated Pigs. Vaccines 2022;10:677. [DOI: 10.3390/vaccines10050677] [Reference Citation Analysis]
3 Müller C, Hrynkiewicz R, Bębnowska D, Maldonado J, Baratelli M, Köllner B, Niedźwiedzka-Rystwej P. Immunity against Lagovirus europaeus and the Impact of the Immunological Studies on Vaccination. Vaccines (Basel) 2021;9:255. [PMID: 33805607 DOI: 10.3390/vaccines9030255] [Reference Citation Analysis]
4 Capucci L, Cavadini P, Lavazza A. Viral haemorrhagic disease: RHDV type 2 ten years later. World Rabbit Sci 2022;30:1-11. [DOI: 10.4995/wrs.2022.16505] [Reference Citation Analysis]
5 O’connor TW, Read AJ, Hall RN, Strive T, Kirkland PD. Immunological Cross-Protection between Different Rabbit Hemorrhagic Disease Viruses—Implications for Rabbit Biocontrol and Vaccine Development. Vaccines 2022;10:666. [DOI: 10.3390/vaccines10050666] [Reference Citation Analysis]